SCHEMBL30935367

SCHEMBL30935367

CC(C)(C)OC(=O)N1CC(C)(C)Oc2ccc(Br)cc21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RORC P51449 2/20 0.39
CCNB2 O95067 1/20 0.37
CDK1 P06493 1/20 0.37
CCNB1 P14635 1/20 0.37
GSK3B P49841 1/20 0.37
CCNB3 Q8WWL7 1/20 0.37
USP30 Q70CQ3 3/20 0.35
BACE1 P56817 6/20 0.35
KDM1A O60341 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
IDO1 P14902 1/20 0.34
GPR183 P32249 1/20 0.33
CTSD P07339 1/20 0.33
ABHD6 Q9BV23 1/20 0.33
NR1H2 P55055 1/20 0.33
SIRT2 Q8IXJ6 1/20 0.33
SIRT1 Q96EB6 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30935046 1.00 RORC (0.39) RORCCCNB2CDK1CCNB1GSK3B
SCHEMBL31694008 0.90 RORC (0.39) RORCCCNB2CDK1CCNB1GSK3B
SCHEMBL691049 0.85 NR1H2 (0.42) USP30KDM1AGPR183NR1H2SIRT2
SCHEMBL30935244 0.83 KDM1A (0.33) KDM1AGPR183NR1H2SIRT2SIRT1
SCHEMBL31693945 0.83 USP30 (0.34) RORCCCNB2CDK1CCNB1GSK3B
SCHEMBL446546 0.82 MAPT (0.45) SIRT2
SCHEMBL30935273 0.81 USP30 (0.41) USP30BACE1KDM1AGPR183NR1H2
SCHEMBL25245307 0.79 NR1H2 (0.37) RORCUSP30BACE1KDM1AABHD6
SCHEMBL18322102 0.79 NR1H2 (0.49) RORCUSP30IDO1GPR183ABHD6
SCHEMBL29404795 0.79 NR1H2 (0.49) RORCUSP30IDO1GPR183ABHD6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024125464-A1 TETRAHYDROISOQUINOLIN-ONE DERIVATIVES, PREPARATION METHODS AND MEDICINAL USES THEREOF JIANGSU HANSOH PHARMACEUTICAL GROUP CO., LTD. (CN) 2024-06-20 WO disclosed